Hematopoietic Stem Cell Colony Classification via Flow Cytometry
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The current colony-forming cell (CFC) assay for detecting hematopoietic stem cells is prone to high variability and lack of reproducibility due to reliance on morphological and phenotypic classification, which is user-dependent and subjective.
Innovation Solution
A method involving the isolation and proliferation of hematopoietic stem cells in a growth factor-containing medium, followed by labeling with marker conjugates specific to CD14, CD235a, and CD15, and subsequent analysis by flow cytometry to standardize and automate the detection and differentiation of colony types.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If morphological and phenotypic classification is used for colony counting, then the method is simple and easy to operate, but the measurement precision and reproducibility are poor due to user-dependent subjectivity
Solution Approach 1:
The patent replaces the manual visual inspection and morphological classification method with flow cytometry-based immunophenotypic analysis. Instead of relying on human operators to visually assess colony morphology under microscopes, the system uses automated flow cytometry to detect and quantify colony-forming cells based on their immunophenotypic markers, thereby substituting a subjective mechanical process with an objective automated analytical system.
Solution Approach 2:
The patent changes the classification parameters from morphological features (visual appearance, size, shape) to immunophenotypic parameters (expression of specific cell surface markers). This parameter transformation enables objective, quantitative measurement using flow cytometry, resolving the contradiction between ease of operation and measurement precision by providing automated, reproducible results based on molecular characteristics rather than subjective visual assessment.
2Measurement precision
If automated flow cytometry with marker conjugates is used, then measurement precision and reproducibility are improved, but device complexity and cost increase
Solution Approach 1:
The patent employs flow cytometry technology, which is a widely used and established technique in cell biology and immunology. By leveraging this universal, multi-functional platform that can analyze multiple parameters simultaneously, the system achieves high measurement precision without requiring entirely new specialized equipment. The same flow cytometer can be used for various cell characterization applications, amortizing the complexity and cost across multiple uses.
Solution Approach 2:
The patent transforms the measurement approach by changing from morphological parameters to immunophenotypic parameters detectable by flow cytometry. This parameter change enables the use of standardized, commercially available reagents and instruments, reducing the need for custom-developed complex systems while achieving superior measurement precision and reproducibility through objective molecular-based detection.
3Ease of manufacture
If manual counting by multiple researchers is performed, then the method requires minimal equipment, but the reliability is poor due to high variability in counting results
Solution Approach 1:
The patent replaces manual counting performed by multiple researchers with automated flow cytometry analysis. This substitution eliminates inter-observer variability and subjectivity inherent in manual methods, providing consistent, reproducible results. The automated system processes all colonies uniformly according to predetermined criteria, ensuring high reliability without requiring multiple operators or complex coordination between them.
Solution Approach 2:
The flow cytometry system performs self-assessment of colony-forming cells based on pre-programmed gating strategies and marker expression thresholds. The instrument automatically acquires data, applies analysis algorithms, and generates results without requiring manual intervention or subjective judgment, thereby achieving high reliability through standardized, automated self-evaluation rather than human-dependent manual counting.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach provides a robust, user-independent, and reproducible method for analyzing hematopoietic stem and progenitor cells, eliminating bias and increasing the accuracy of colony classification and quantification.
Implementation Method 1
contacting the cell colonies with one or more marker conjugates comprising at least one detection moiety and at least one antigen recognizing moiety against CD14, CD235a and CD15
Implementation Method 2
detecting the relative amount of differentiated hematopoietic stem cells in a cell colony labelled with the marker conjugates
Data Source
Figure 1
Figure 2
Figure 3a
AI summary
The invention is directed to a Method for detecting differentiated hematopoietic cells comprising the steps: a) isolation of undifferentiated hematopoietic stem cells in groups of 1 - 1000 cells on a support b) proliferating the isolated cells to form cell colonies of differentiated hematopoietic cells by providing cell media comprising a growth factor c) contacting the cell colonies with one or more marker conjugates comprising at least one detection moiety and at least one antigen recognizing moiety against CD14, CD235a and CD15 d) detecting the relative amount of differentiated hematopoietic stem cells in a cell colony labelled with the marker conjugates.